semaglutide 7.2 mg RYBELSUS® Side Effects Novo Nordisk announced headline results

4 Berberine- 60

Roche reported positive Phase II topline data showing that its once-weekly dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonist CT-388 achieved substantial, sustained, and dose-dependent weight loss through 48 weeks

How retatrutide works: the first triple agonist targeting GIP, GLP-1, and glucagon receptors

Compounded semaglutide with B12 is gaining attention for weight loss and diabetes management

Products are supported by batch-level testing using HPLC and mass spectrometry to confirm identity and purity

Organic Rice Extract, Ester of Glycerol (probiotic digestive resistant coating)